Get started
Author

Gus Khursigara

Observed names: G. Khursigara, Khursigara G
Observed institutions: Scripps Research Institute, Cornell University, NYU Langone Health, Alexion Pharmaceuticals (United States), Weill Cornell Medicine, Inozyme Pharma (United States), Alexion Pharma (Switzerland), New York University
ORCID: 0000-0003-4041-530X
Observed ORCID: 0000-0003-4041-530X
OpenAlex ID: A5041136549
Akt Phosphorylates and Negatively Regulates Apoptosis Signal-Regulating Kinase 1
2001 · Albert H. Kim, Gus Khursigara, et al. · Molecular and Cellular Biology · 723
Baseline characteristics and disease burden in patients in the International Paroxysmal Nocturnal Hemoglobinuria Registry
2014 · H. Schrezenmeier, P. Muus, et al. · Haematologica · 280
PDF
Association of the p75 Neurotrophin Receptor with TRAF6
1999 · Gus Khursigara, Jason R. Orlinick, et al. · Journal of Biological Chemistry · 247
Long‐term effect of the complement inhibitor eculizumab on kidney function in patients with paroxysmal nocturnal hemoglobinuria
2010 · Peter Hillmen, Modupe Elebute, et al. · American Journal of Hematology · 239
Transformation of Lupus-Inducing Drugs to Cytotoxic Products by Activated Neutrophils
1994 · Xiaoxia Jiang, Gus Khursigara, et al. · Science · 233
The uniqueness of being a neurotrophin receptor
2001 · Francis S Lee, Albert H Kim, et al. · Current Opinion in Neurobiology · 195
A Prosurvival Function for the p75 Receptor Death Domain Mediated via the Caspase Recruitment Domain Receptor-Interacting Protein 2
2001 · Gus Khursigara, John Bertin, et al. · Journal of Neuroscience · 185
PDF
The management of pregnancy in paroxysmal nocturnal haemoglobinuria on long term eculizumab
2010 · Richard Kelly, Louise Arnold, et al. · British Journal of Haematology · 167
PDF
Prophylactic Eculizumab after Renal Transplantation in Atypical Hemolytic–Uremic Syndrome
2010 · Lothar Bernd Zimmerhackl, Johannes Hofer, et al. · New England Journal of Medicine · 143
PDF
p75 neurotrophin receptor as a modulator of survival and death decisions
1999 · Patrizia Casaccia-Bonnefil, Chenghua Gu, et al. · Microscopy Research and Technique · 111
Ectopic Calcification and Hypophosphatemic Rickets: Natural History of ENPP1 and ABCC6 Deficiencies
2021 · Carlos R Ferreira, Kristina Kintzinger, et al. · Journal of Bone and Mineral Research · 74
Safety and efficacy of the terminal complement inhibitor eculizumab in Japanese patients with paroxysmal nocturnal hemoglobinuria: the AEGIS Clinical Trial
2011 · Yuzuru Kanakura, Kazuma Ohyashiki, et al. · International Journal of Hematology · 72
Autoantibodies to Cryptic Epitopes of C-Reactive Protein and other Acute Phase Proteins in the Toxic Oil Syndrome
1995 · Susanne A. Bell, Terry W. Du Clos, et al. · Journal of Autoimmunity · 31
A Reference Range for Plasma Levels of Inorganic Pyrophosphate in Children Using the ATP Sulfurylase Method
2021 · Eva Bernhard, Yvonne Nitschke, et al. · The Journal of Clinical Endocrinology & Metabolism · 28
Modification of the Eculizumab Dose to Successfully Manage Intravascular Breakthrough Hemolysis in Patients with Paroxysmal Nocturnal Hemoglobinuria.
2008 · Richard Kelly, Louise Arnold, et al. · Blood · 28
Eculizumab in paroxysmal nocturnal hemoglobinuria with Budd-Chiari syndrome progressing despite anticoagulation
2012 · Andrés Brodsky, Octavio Mazzocchi, et al. · Experimental Hematology and Oncology · 23
PDF
Musculoskeletal Comorbidities and Quality of Life in ENPP1-Deficient Adults and the Response of Enthesopathy to Enzyme Replacement Therapy in Murine Models
2020 · Carlos R. Ferreira, Anenya Jai Ansh, et al. · Journal of Bone and Mineral Research · 22
PDF
ENPP1 deficiency: A clinical update on the relevance of individual variants using a locus‐specific patient database
2022 · Stephanie A. Mercurio, Lauren M. Chunn, et al. · Human Mutation · 20
Phenotypic characterization of ENPP1 deficiency: generalized arterial calcification of infancy and autosomal recessive hypophosphatemic rickets type 2
2025 · Carlos R Ferreira, Mary E Hackbarth, et al. · JBMR Plus · 10
Effects of food, fasting, and exercise on plasma pyrophosphate levels and ENPP1 activity in healthy adults
2023 · Gus Khursigara, Pedro Huertas, et al. · Bone · 8
Evaluation of Paroxysmal Nocturnal Hemoglobinuria Disease Burden: The Patient's Perspective. A Report From the International PNH Registry.
2010 · Petra Muus, Jeffrey Szer, et al. · Blood · 7
Lifelong impact of ENPP1 Deficiency and the early onset form of ABCC6 Deficiency from patient or caregiver perspective
2022 · Christine O’Brien, Gus Khursigara, et al. · PLoS ONE · 5
PDF
Erratum: “Long‐term effect of the complement inhibitor eculizumab on kidney function in patients with paroxysmal nocturnal hemoglobinura” by Hillmen et al., Am J Hematol 553–559, 2010, DOI number 21757
2010 · Peter Hillmen, Modupe Elebute, et al. · American Journal of Hematology · 5
PDF
Successful Pregnancy Outcomes in Paroxysmal Nocturnal Hemoglobinuria with Long-Term Eculizumab Treatment
2008 · Richard Kelly, Louise Arnold, et al. · Blood · 5
Eculizumab for patients with paroxysmal nocturnal hemoglobinuria (PNH) is effective during the maintenance of hemodialysis for end stage renal failure
2010 · R.J. Kelly, A. Hill, et al. · Leukemia Research · 4
Works count: 41
Citation count: 2,872
H-index: 18
I10-index: 19
Year
Topic
Type